Ellagic acid exerts anti-proliferation effects via modulation of Tgf-B/Smad3 signaling in MCF-7 breast cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 273-276

  Zhang, Tao ^a   Chen, Hong Sheng ^a   Wang, Li Feng ^b   Bai, Ming Han ^a   Wang, Yi Chong ^a   Jiang, Xiao Feng ^a   Liu, Ming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemoprevention; Ellagic acid; MCF 7 breast cancer cells; SIS3; Smad3; TGF Smad3 pathway

Indexed keywords

6,7 DIMETHYL 2 (2E) 3 (1 METHYL 2 PHENYL 1H PYRROLO(2,3 B)PYRIDIN 3 YL PROP 2 ENOYL) 1,2,3,4 TETRAHYDROISOQUINOLINE HYDROCHLORIDE; 6,7-DIMETHYL-2-(2E)-3-(1-METHYL-2-PHENYL-1H-PYRROLO(2,3-B)PYRIDIN-3-YL-PROP-2-ENOYL)-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ELLAGIC ACID; ISOQUINOLINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; RETINOBLASTOMA PROTEIN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ELLAGIC ACID; GENE EXPRESSION; HUMANS; ISOQUINOLINES; MCF-7 CELLS; PYRIDINES; PYRROLES; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84894093551     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.273     Document Type: Article

References (13)

1. Adams LS, Phung S, Yee N, et al (2010). Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res, 70, 3594-605.
2. Chen HS, Liu M, Shi LJ, et al (2011). Effects of raspberry phytochemical extract on cell proliferation, apoptosis, and serum proteomics in a rat model. J Food Sci, 76, T192-8.
3. Derynck R, Zhang YE (2003). Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature, 425, 577-84.
4. Jinnin M, Ihn H, Tamaki K (2006). Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-1-Induced Extracellular Matrix Expression. Mol Pharmacol, 69, 597-607.
5. Leaslc A, Abraham DJ (2004). TGF-β signaling and the fihrotic response. FASEB J, 18, 816-27.
6. Li TM, Chen GW, Su CC, et al (2005). Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res, 25, 971-9.
7. Maiti B, Li J, de Bruin A, Gordon F J, et al (2005). Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem, 280, 18211-20.
8. Müller H, Moroni MC, Vigo E, et al (1997). Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol, 17, 5508-20.
9. Narayanan BA, Re GG (2001). IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res, 21, 359-64.
10. Su E, Han X, Jiang G (2010). The transforming growth factor beta 1-SMAD signaling pathway involved in human chronic myeloid leukemia. Tumor, 96, 659-66.
11. Tian F, DaCosta Byfield S, et al (2003). Reduction in Smad2/3Signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res, 63, 8284-A92.
12. Xu Y, Pasche B (2007). TGF-β signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet, 16, R14-R20.
13. Yu B, Lane ME, Wadler S (2002). SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells. Biochem Pharmacol, 64, 1091-100.